Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Berberine and Interferons

supplement:

Berberine

Research Papers that Mention the Interaction

Oral … of BBR inhibited the NF-κB signal transduction pathway, reduced the … of pro-inflammatory cytokines [interleukin (IL)-1β, IL-6, interferon-γ , and tumor necrosis factor-α], promoted the expression of anti-inflammatory cytokines (IL-10 and transforming growth factor-β), and improved the terminal ileum tissue inflammation.
World journal of gastroenterology  •  2019  |  View Paper
Serum levels of tumor necrosis factor (TNF)-alpha, interferon (IF)-gamma, interleukin (IL)-2, and IL-1beta were reduced by berberine pre-treatment; levels of serum IL-10, an anti-inflammatory cytokine, was elevated.
Medical science monitor : international medical journal of experimental and clinical research  •  2017  |  View Paper
Our findings also demonstrate that berberine significantly down‐regulates LPS‐ or interferon (IFN)‐γ‐induced nitric oxide synthase (iNOS) and cyclo‐oxygenase‐2 (COX‐2) expression in BV‐2 microglia cells.
Journal of cellular biochemistry  •  2010  |  View Paper
The administration of berberine significantly reduced plasma TNF-α, IFN-γ , and NO levels, but did not suppress plasma IL-12 levels in mice exposed to LPS.
Acta Pharmacologica Sinica  •  2006  |  View Paper
Importantly, berberine pretreatment of macrophages increased their ability to induce interferon‐γ (IFN‐γ) and reduced their ability to induce IL‐4 in antigen‐primed CD4+ T cells.
Immunology  •  2003  |  View Paper
The results showed that BBR could significantly improve the pathological characteristics of gastric tissue, alleviate the serum biochemical indexes and reduce the mRNA expression of nuclear factor-κB, tumor necrosis factor-α, Cyclooxygenase-2, monocyte chemoattractant protein-1, Interleukin-17A and I interferon-γ.
European journal of pharmacology  •  2021  |  View Paper